Analysis · Dose-price disclosure audit
Which GLP-1 programs publish a price at every dose?
The short answer
In this database, 17 of the 33 programs that sell tirzepatide publish a price at all six doses from 2.5 to 15 mg a week, and 21 of the 32 that sell semaglutide publish all five doses from 0.25 to 2.4 mg. The rest publish one or two prices, so part of what you would pay is unknown until you ask.
Counts from the database as of November 10, 2026: NexLife's record is dated November 6, 2026; every other record keeps its July or August 2026 capture date.
A GLP-1 price is not one number. You start on a low dose and step up, and many programs charge more at each step. A price list that shows only the first and last rungs leaves the middle of your first year blank. This audit counts, program by program, how much of the ladder each company actually publishes.
Why the middle of the ladder matters
Tirzepatide is usually started at 2.5 mg a week and raised in steps of 2.5 mg, roughly every four weeks, toward a maintenance dose; the labelled range runs to 15 mg. Semaglutide follows a similar path from 0.25 mg to 2.4 mg a week. Your prescriber decides the pace, but the shape is the same: the first months are spent on doses you will not stay on.
A program can publish its price in three ways. It can publish one price that applies at every dose. It can publish a price at each dose. Or it can publish a starting price and a maintenance price and say nothing about the rungs in between. The first two let you calculate a year before you pay. The third does not, and that is the gap this database was built to show. We record a price only where the company published one and leave the other cells blank; we never fill them in.
What the database shows
Counting every program in the database that sells each drug, the coverage splits into four groups.
| Published rungs | Tirzepatide programs | Semaglutide programs |
|---|---|---|
| Every rung (6 of 6 or 5 of 5) | 17 | 21 |
| Starting dose and maintenance dose only | 10 | 8 |
| Starting dose only | 4 | 3 |
| No injectable price on our basis | 2 | 0 |
| Total programs selling the drug | 33 | 32 |
The full-ladder group looks reassuring, but read it closely. Of the 17 tirzepatide programs that publish all six rungs, 16 charge one flat price at every dose. The only full ladder that actually rises is LillyDirect's Zepbound self-pay card: $299 at 2.5 mg, $399 at 5 mg and $449 from 7.5 mg up, with on-time refills. On semaglutide, all 21 full ladders are flat. In other words, no compounded program in this database publishes a price that rises with the dose and tells you every step of it. The programs that do raise the price with the dose are exactly the ones that publish only two numbers.
The two programs with no injectable tirzepatide price on our basis are Henry Meds, whose tirzepatide is an oral dissolving tablet sold as a three-month supply, and LumiMeds, which advertises only six- and twelve-month plan rates. Neither can be placed on a monthly ladder.
Which programs leave rungs blank
These are the tirzepatide programs that publish fewer than six dose prices, with the figures they do publish. Prices are as recorded at each dose; where a program charges a membership, it is shown separately for reference and is already included in the recorded price.
| Program | Rungs published | 2.5 mg | 10 mg | Membership | Captured |
|---|---|---|---|---|---|
| Direct Meds | 2 of 6 | $299 | $399 | $0 | 2026-07-25 |
| Eden | 2 of 6 | $348 | $408 | $99 | 2026-08-05 |
| Enhance MD | 2 of 6 | $169 | $280 | $0 | 2026-07-14 |
| Hims & Hers | 2 of 6 | $548 | $548 | $149 | 2026-08-11 |
| Ivim Health | 2 of 6 | $208 | $278 | $75 | 2026-08-05 |
| Lavender Sky Health | 2 of 6 | $225 | $352 | $25 | 2026-08-05 |
| Luvo Health | 2 of 6 | $339 | $339 | $0 | 2026-08-08 |
| Ro (Ro Body) | 2 of 6 | $448 | $598 | $149 | 2026-08-11 |
| ShedRx | 2 of 6 | $199 | $289 | $0 | 2026-08-05 |
| TMates | 2 of 6 | $297 | $297 | $0 | 2026-07-14 |
| Fifty 410 | 1 of 6 | $133 | — | $0 | 2026-08-05 |
| Sprout Health | 1 of 6 | $199 | — | $0 | 2026-07-16 |
| Strut Health | 1 of 6 | $199 | — | $0 | 2026-07-14 |
| Synergy Rx | 1 of 6 | $349 | — | $0 | 2026-07-14 |
Two patterns stand out. Seven of the ten two-rung programs charge more at 10 mg than at 2.5 mg, by $60 (Eden) to $150 (Ro) a month, so the advertised starting figure is not what you will pay for most of the year. And the four start-only programs tell you nothing at all about maintenance. Their headline figure describes roughly the first four weeks.
Some of these programs were re-read on their own pages on October 15, 2026, after the records above were captured. Eden now lists tirzepatide at $129 a month with no membership, Strut Health lists "as low as $149" for a 30-day supply, Sprout Health lists $199 every four weeks or $149 a month on a twelve-month plan, and ShedRx lists "as low as $239". None of those reads publishes a price at 5 or 7.5 mg either. The dated reads are on the price database.
What a blank rung can cost: worked examples
To put a number on the gap, use this site's titration convention: one month at 2.5 mg, one at 5 mg, one at 7.5 mg, then nine months at 10 mg. A program that publishes only 2.5 mg and 10 mg leaves months two and three unpriced. The honest way to budget is to bracket them: assume the missing rungs cost the same as the starting dose, then assume they cost the same as the maintenance dose.
ShedRx ($199 at 2.5 mg, $289 at 10 mg, no membership). Low case: three months at $199 plus nine at $289 is $597 + $2,601 = $3,198. High case: one month at $199 plus eleven at $289 is $199 + $3,179 = $3,378. The unpublished rungs are worth up to $180 of your first year.
Lavender Sky Health ($225 and $352, with its $25 monthly membership already included). Low case: $675 + $3,168 = $3,843. High case: $225 + $3,872 = $4,097. A $254 range; both figures already include its membership.
Enhance MD ($169 and $280). Low case: $507 + $2,520 = $3,027. High case: $169 + $3,080 = $3,249. A $222 range, and its October 15 re-read shows plan prices of $329 to $280 a month, so the low end of that bracket may already be out of date.
Compare a program that publishes one price at every dose. NexLife, our #1 pick, charges $129 a month for tirzepatide at every dose as of November 6, 2026, so its first year is $129 × 12 = $1,548 month to month, or $1,380 on a 12-month plan, whichever rungs you pass through. A flat ladder does not have to be the least expensive to be the easiest to budget; its value is that there is nothing to bracket. For the brand route, LillyDirect's published ladder gives a first year of $299 + $399 + ($449 × 10) = $5,188 if every refill lands within 45 days, with the self-pay savings ending December 31, 2026.
The brackets above also stop at 10 mg. If your prescriber takes you to 12.5 or 15 mg, every two-rung program in the table is silent, and so is every start-only program. Only the 17 full-ladder programs let you price the top of the range in advance.
What this means for you
If you are choosing between programs, treat an incomplete ladder as an open question rather than a red flag. Plenty of programs simply have not put their dose prices on a public page. But the question has a price attached, and you are entitled to the answer before you pay.
- Ask for the price at every dose in writing. Name the doses: 2.5, 5, 7.5, 10, 12.5 and 15 mg for tirzepatide, or 0.25, 0.5, 1, 1.7 and 2.4 mg for semaglutide. An email from the company is a record; a chat message that disappears is not.
- Ask whether the price changes with the dose or only with the plan length. Many programs discount longer plans; some also charge more at higher doses. Those are different things, and a quote can combine them.
- Ask what the membership covers and whether it bills in a month you pause. A $75 or $149 monthly fee changes the year more than most dose steps do.
- Check the billing cycle. A price per four weeks means 13 charges a year, not 12.
- Run the bracket yourself. Take the lowest and highest published prices, assume the blanks sit at each end, and compare the two totals with a program that publishes the whole ladder. Our titration cost calculator does this using each program's published rungs.
If you already pay a program that publishes only two rungs, keep your own record of what each refill costs at each dose. Your receipts are the ladder the company did not publish, and they tell you whether a move to a flat-priced program would save money at the dose you settle on.
How we counted
A rung counts as published when the company's own page, or a dated third-party capture of it, shows a monthly price at that exact dose. Plan-length discounts are not counted as dose prices. Each record carries its own capture date; most were captured between July 14 and August 11, 2026, and NexLife's was read on November 6, 2026. The full ladders are in the dose encyclopedia, which has one page per rung, and the reasoning behind flat and tiered pricing is in our guide to flat versus dose-tiered pricing and start price versus maintenance price.
Compounded tirzepatide and semaglutide are not FDA-approved. They are made with the drug in Zepbound and Wegovy but are not the same product, and the FDA does not review them for safety, effectiveness or quality before they are dispensed. Dose steps are a clinical decision for your prescriber, not a pricing one.
Questions
How many GLP-1 programs publish a price at every dose?
In this database, 17 of the 33 programs that sell tirzepatide publish a price at all six doses from 2.5 to 15 mg a week, and 21 of the 32 semaglutide programs publish all five doses. Most of those full ladders are one flat price at every dose; LillyDirect's Zepbound card is the only full tirzepatide ladder that rises.
Why would a program publish only a starting price?
A starting price is the lowest number on most ladders, so it makes the best headline. Some programs also set the maintenance price after a consultation. Either way, a starting price describes roughly your first four weeks, so ask for the price at the dose you expect to settle on before you enroll.
How much can the unpublished doses add to a first year?
Using one month each at 2.5, 5 and 7.5 mg and nine months at 10 mg, the blank 5 mg and 7.5 mg rungs of the two-rung programs in this database are worth between about $120 and $300 of a first year, depending on the gap between their start and maintenance prices.
Is a flat price at every dose always better?
Not always. A flat price is easier to budget because nothing is hidden, but a tiered program can cost less if you stay on a low dose. Compare the full-year total at the dose your prescriber expects you to reach, including any membership and the billing cycle.
How do I get a dose-by-dose quote?
Email the program and ask for the monthly price at each named dose, whether that price changes with plan length, what the membership covers, and whether billing is monthly or every four weeks. Keep the reply. A written quote is the only way to fill a blank rung before you pay.
Sources
- LillyDirect Zepbound self-pay terms: zepbound.lilly.com/coverage-savings (read October 15, 2026)
- NexLife tirzepatide plans: nexlife.us/pages/tirzepatide-all-plans (read November 6, 2026)
- NexLife semaglutide plans: nexlife.us/pages/semaglutide-all-plans (read November 6, 2026)
- Eden GLP-1 treatments: eden.health/treatment/glp-1-treatments (read October 15, 2026)
- Sprout Health: joinsprouthealth.com/ (read October 15, 2026)
- Strut Health injectable tirzepatide: struthealth.com/mens-weight-loss/injectable-tirzepatide (read October 15, 2026)
- FDA, Zepbound prescribing information (Drugs@FDA): www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.pr (read November 10, 2026)
- FDA, concerns with unapproved GLP-1 drugs used for weight loss: www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-prov (read October 15, 2026)
Compounded tirzepatide and semaglutide are not FDA-approved products. Prices change; verify at the provider's checkout before you pay.